Hantaviruses and cardiopulmonary syndrome in South America
Introduction
Hantaviruses are important zoonotic pathogens related to rodents and other small mammals (shrews, moles and bats). When infecting man, hantaviruses can cause severe diseases with high case-fatality rates such as hemorrhagic fever with renal syndrome (HFRS) in Asia and Europe and hantavirus cardiopulmonary syndrome (HCPS) in the Americas. In both syndromes, capillary leakage of intravascular fluid into interstitial tissue leads to respiratory and renal failure and shock (Jonsson et al., 2010). However, a recent comparative analysis of HFRS and HCPS cases has revealed that syndromic names are mostly didactic and, in fact, patients from the Americas also have renal failure and patients from Europe and Asia have respiratory failure. Thus, the worldwide use of the term Hantavirus disease has been recently proposed (Clement et al., 2012; see also chapter X of this Special Issue).
The first case of an American hantavirus producing human disease, a cardiopulmonary syndrome caused by Sin Nombre virus (SNV), was reported in the United States Hughes et al. (1993). Dozens of hantavirus genotypes have been reported since then in the Americas associated with autochthonous rodent species of the subfamily Neotominae, Sigmodontinae and Arvicolinae (Jonsson et al., 2010). In South America, hantavirus reservoirs are Sigmodontinae American rodents that harbor the following viruses associated with human disease: Andes, Maciel, Oran, Lechiguanas, Laguna Negra and Bermejo in Argentina, Andes in Chile, Laguna Negra and Bermejo in Paraguay, Laguna Negra, Tunari and Bermejo in Bolivia, Maripa in French Guyana, Juquitiba, Andes and Lechiguanas in Uruguay, and Araraquara, Juquitiba/Araucária, Castelo dos Sonhos, Laguna Negra and Anajatuba in Brazil (Firth et al., 2012). A map of South America showing hantaviruses associated with disease and their rodent reservoirs is shown in Fig. 1.
Hantavirus disease is an emerging health problem in South America due to urban growth and the expansion of agriculture and cattle-raising areas into ecosystems containing most of the species of Sigmodontinae rodents that act as hantavirus reservoirs (Figueiredo et al., 2009b). The biodiversity of natural ecosystems of South America supports about 500 known species of Sigmodontinae (Mills, 2006, Mills et al., 2007).
The transmission of hantavirus to man occurs mostly by contact with or through aerosols of excreta and secretions of infected rodents (Butler and Peters, 1994), although human-to-human transmission of hantavirus has been reported in Argentina and Chile (Martinez et al., 2005, Padula et al., 1998, Wells et al., 1997).
Section snippets
The virus
Hantaviruses constitute a genus of the family Bunyaviridae that includes a large number of small mammal-borne viruses distributed worldwide. The hantavirus RNA genome, packed in particles 80 to 120 nm in size, comprises RNA of approximately 12,000 nucleotides divided into three negative-sense and single-stranded fragments (Schmaljohn and Dalrymple, 1983). These are named S (small), M (medium), and L (large) and encode the nucleoprotein (N), envelope glycoproteins (Gn and Gc), and the L protein
Epidemiology
In South America, the diversity and the distribution of hantavirus is highly complex (Padula et al., 2007). The eco-epidemiology of hantavirus depends on the microhabitat of its reservoir (Mills and Childs, 1998). Landscape composition, climate and seasonality, human agricultural activity and environmental degradation are important factors of hantavirus epidemiology. Based on phylogenetic studies of complete nucleotide sequences of the N gene, South American hantavirus strains or genetic
HCPS
About 4000 HCPS cases have been reported in the Americas since 1993, caused by more than 30 hantavirus strains or genetic lineages. Almost half of these HCPS cases occurred in Brazil where the disease is commonly seasonal. In the Cerrado regions of the Southeast and Central Plateau, HCPS is mostly reported from April through September during the dry winter season when agricultural activity is intense.
HCPS is a severe acute disease associated with a rapid onset of respiratory failure and
Pathogenesis
Hantavirus infects endothelial cells, altering capillary permeability and leading to acute pulmonary edema and HCPS Fig. 2 (Gavrilovskaya et al., 2012). Therefore, the hantavirus infection induces an inflammatory process with a strong immune response that may be the most important cause of disruption of the endothelial barrier. A cytokine study in 21 HCPS patients infected with ARQV showed that IL-6 may have an important role in the pathogenesis of HCPS, being associated with a fatal outcome (
Laboratory diagnosis
Considering that HCPS is a fast evolving disease commonly confused with other severe diseases such as bacterial sepsis, it is important to collect early clinical samples for testing with rapid diagnostic methods. Sensitive and rapid diagnostic tests have been developed based on the detection of anti-hantavirus IgM and IgG antibodies and on the viral genome (Machado et al., 2009).
IgM and IgG antibodies to the hantavirus structural proteins (N, Gn and Gc) are detectable in practically all HCPS
Management
Ribavirin has been successfully used for the treatment of HFRS in Chinese patients. When initiated in the first week of illness, ribavirin reduces oliguria and renal insufficiency. However, the use of ribavirin in HCPS patients has shown inconclusive results and had no apparent clinical benefit (Chapman et al., 2002, Mertz et al., 2006).
The administration of human neutralizing antibodies to HCPS patients in the viremic phase might be effective as treatment. Studies of passive transfer of sera
Prophylaxis
An inactivated virus vaccine against hantavirus is extensively used in China and Korea. Approximately 2 million doses of HFRS vaccines derived from inactivated rodent brain or cell culture are given annually in China and were able to reduce the number of HFRS cases to less than a half (Zhang et al., 2010) (Kruger et al., 2011). There is no vaccine available for American hantavirus. The development of a vaccine for American hantavirus is difficult due to the lack of an animal model of hantavirus
Acknowledgments
We acknowledge the Brazilian National Research Council (CNPq) for Grant 302509/87-9/BM/FV and the São Paulo State Research Council (FAPESP) for Grant 12/24150-9. We also acknowledge Mrs. Elettra Greene for review of the manuscript.
References (127)
- et al.
Role of mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis of hantavirus pulmonary syndrome
Microbes Infect.
(2008) - et al.
Hantavirus cardiopulmonary syndrome: immune response and pathogenesis
Microbes Infect.
(2006) - et al.
Assessment of person-to-person transmission of hantavirus pulmonary syndrome in a Chilean hospital setting
J. Hosp. Infect.
(1998) - et al.
Hantavirus pulmonary syndrome: prognostic factors for death in reported cases in Brazil
Trans. R. Soc. Trop. Med. Hyg.
(2012) - et al.
Isolation, characterization and geographic distribution of Cano Delgadito virus, a newly discovered South American hantavirus (family Bunyaviridae)
Virus Res.
(1997) - et al.
Phylogenetic analysis of the S segment from Juquitiba hantavirus: identification of two distinct lineages in Oligoryzomys nigripes
Infect., Genet. Evol.
(2013) - et al.
Hantavirus infection in Brazilian patients from Recife with suspected leptospirosis
Lancet
(1993) - et al.
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)
Vaccine
(2013) - et al.
Laguna Negra virus associated with HPS in western Paraguay and Bolivia
Virology
(1997) - et al.
Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus
Virology
(1998)
Evidence of circulation of Laguna Negra-like hantavirus in the central west of Brazil: case report
J. Clin. Virol.
A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant
Scand. J. Infect. Dis.
A retrospective serologic survey of hantavirus infections in the county of Cassia dos Coqueiros, State of Sao Paulo, Brazil
Rev. Soc. Bras. Med. Trop.
Hantavirus in Chile: review and cases analysis since 1975
Rev. Med. Chil.
Polymorphisms in human leukocyte antigens, human platelet antigens, and cytokine genes in hantavirus cardiopulmonary syndrome patients from Ribeirão Preto, Brazil
J. Med. Virol.
Association of −308G/A polymorphism in the tumor necrosis factor-alpha gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirao Preto region, Brazil
Arch. Virol.
Radiographic findings in 20 patients with hantavirus pulmonary syndrome correlated with clinical outcome
AJR Am. J. Roentgenol.
Hantaviruses and hantavirus pulmonary syndrome
Clin. Infect. Dis.
Pulmonary and cardiovascular syndrome due to hantavirus: clinical aspects of an emerging disease in southeastern Brazil
Rev. Soc. Bras. Med. Trop.
Serological survey of hantavirus in Jardinopolis County, Brazil
J. Med. Virol.
Hantavirus pulmonary syndrome in Central Bolivia: relationships between reservoir hosts, habitats, and viral genotypes
Am. J. Trop. Med. Hyg.
Hantavirus pulmonary syndrome (Rio Mamore virus) in the Peruvian Amazon region
Revista peruana de medicina experimental y salud publica
Prevalence of antibodies to hantavirus among family and health care worker contacts of persons with hantavirus cardiopulmonary syndrome: lack of evidence for nosocomial transmission of Andes virus to health care workers in Chile
Am. J. Trop. Med. Hyg.
Serologic evidence for human hantavirus infection in Peru
Vector Borne Zoonotic Dis.
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome
Clin. Infect. Dis.
The complex ecology of hantavirus in Paraguay
Am. J. Trop. Med. Hyg.
A unifying hypothesis and a single name for a complex globally emerging infection: hantavirus disease
Eur. J. Clin. Microbiol. Infect. Dis.
Novel strain of Andes virus associated with fatal human infection, central Bolivia
Emerg. Infect. Dis.
Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine
J. Virol.
Hantavirus pulmonary syndrome: report of the first three cases in Sao Paulo, Brazil
Rev. Inst. Med. Trop. Sao Paulo
Natural host relationships and genetic diversity of rodent-associated hantaviruses in southeastern Brazil
Intervirology
Yellow pigmy rice rat (Oligoryzomys flavescens) and hantavirus pulmonary syndrome in Uruguay
Emerg. Infect. Dis.
Juquitiba-like hantavirus from 2 nonrelated rodent species, Uruguay
Emerg. Infect. Dis.
Hantavirus epidemiological studies in Brazilian Sigmodontinae rodents
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group
N. Engl. J. Med.
Hantavirus infection in people inhabiting a highly endemic region of the Gran Chaco territory, Paraguay: association with Trypanosoma cruzi infection, epidemiological features and haematological characteristics
Ann. Trop. Med. Parasitol.
High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco
Am. J. Trop. Med. Hyg.
Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile
J. Infect. Dis.
Presence of Andes virus genome in gingival crevicular fluid during acute hantavirus infection
Diagnosis of hantavirus infection in humans and rodents in Ribeirao Preto, State of Sao Paulo, Brazil
Rev. Soc. Bras. Med. Trop.
Evaluation of an enzyme-linked immunosorbent assay based on Araraquara virus recombinant nucleocapsid protein
Am. J. Trop. Med. Hyg.
Expression of a hantavirus N protein and its efficacy as antigen in immune assays
Braz. J. Med. Biol. Res.
Hantavirus pulmonary syndrome, central plateau, southeastern, and southern Brazil
Emerg. Infect. Dis.
Diversity and distribution of hantaviruses in South America
J. Virol.
The role of the endothelium in HPS pathogenesis and potential therapeutic approaches
Adv. Virol.
Serological evidence of hantavirus infection in rural and urban regions in the state of Amazonas, Brazil
Mem. Inst. Oswaldo Cruz
Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome
J. Virol.
Prevalence of antibody to hantaviruses in humans and rodents in the Caribbean region of Colombia determined using Araraquara and Maciel virus antigens
Mem. Inst. Oswaldo Cruz
Hantavirus pulmonary syndrome: an emerging infectious disease
Science
Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter
J. Med.Virol.
Cited by (85)
Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study
2024, The Lancet Infectious DiseasesDirect and indirect effects of Puumala hantavirus on platelet function
2024, Thrombosis ResearchHantavirus in humans: a review of clinical aspects and management
2023, The Lancet Infectious DiseasesSafety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study
2024, Journal of Infectious DiseasesHantavirus Disease: A Global Update over the Last Decade
2024, Rising Contagious Diseases: Basics, Management, and Treatments